Biovica International AB (publ) (STO:BIOVIC.B)
Sweden · Delayed Price · Currency is SEK 0.3600
+0.0180 (5.26%)
At close: Mar 27, 2026
Biovica International AB Market Cap
Biovica International AB has a market cap or net worth of 105.09 million as of March 27, 2026. Its market cap has decreased by -35.57% in one year.
Market Cap
105.09M
Enterprise Value
21.70M
Revenue
10.93M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.36
Market Cap Chart
Since March 29, 2017, Biovica International AB's market cap has decreased from 210.00M to 105.09M, a decrease of -49.96%. That is a compound annual growth rate of -7.40%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 27, 2026 | 105.09M | -2.70% |
| Dec 30, 2025 | 108.01M | -44.77% |
| Dec 30, 2024 | 195.57M | -9.82% |
| Dec 29, 2023 | 216.86M | -41.83% |
| Dec 30, 2022 | 372.79M | -68.37% |
| Dec 30, 2021 | 1.18B | -18.58% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Mar 29, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Simris Group AB (PUBL) | 133.63M |
| IRLAB Therapeutics AB | 128.26M |
| Xbrane Biopharma AB | 124.15M |
| Active Biotech AB | 114.67M |
| Alligator Bioscience AB | 106.53M |
| Annexin Pharmaceuticals AB | 98.12M |
| Scandinavian ChemoTech AB | 96.73M |
| Alzinova AB | 91.12M |